Cargando…
Colchicine and coronary heart disease risks: A meta-analysis of randomized controlled clinical trials
BACKGROUND: Several trials have considered the safety and clinical benefits of colchicine as a treatment option for secondary prevention in patients with coronary atherosclerotic heart disease (CAD), but its safety and clinical benefits remain controversial. The purpose of this study was to explore...
Autores principales: | Ma, Zijun, Chen, Jun, Jin, Kaiqin, Chen, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512890/ https://www.ncbi.nlm.nih.gov/pubmed/36176989 http://dx.doi.org/10.3389/fcvm.2022.947959 |
Ejemplares similares
-
Colchicine for prevention of post-operative atrial fibrillation: Meta-analysis of randomized controlled trials
por: Ge, Peibing, et al.
Publicado: (2022) -
Colchicine for Coronary Artery Disease: A Review
por: Chen, Tao, et al.
Publicado: (2022) -
Colchicine efficacy comparison at varying time points in the peri-operative period for coronary artery disease: a systematic review and meta-analysis of randomized controlled trials
por: Wei, Zhi-Yang, et al.
Publicado: (2023) -
Colchicine and diabetes in patients with chronic coronary artery disease: insights from the LoDoCo2 randomized controlled trial
por: Mohammadnia, Niekbachsh, et al.
Publicado: (2023) -
A Meta-Analysis Evaluating the Colchicine Therapy in Patients With Coronary Artery Disease
por: Grajek, Stefan, et al.
Publicado: (2021)